Systemic administration of beta‐blockers vs placebo or no treatment
Progression to stage 2 with plus disease · Prevention of retinopathy of prematurity in preterm infants
Systemic administration of beta‐blockers showed no clear difference in progression to stage 2 with plus disease compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
- Beta‐blockers for prevention and treatment of retinopathy of prematurity in preterm infants 2018 · Cochrane Headline outcomes onlyRR 0.25 [0.03, 2.16]2 studies · 161 participantsModerate